Log in
Log in

Category: Courses

ASCO 2026 Update – Advanced Ovarian Cancer

This Medudy course is a video podcast for physicians on the topic of “Primary vs. Interval Surgery in Advanced Ovarian Cancer.” Prof. Dr. Sven Mahner and Prof. Dr. Fabian Trillsch discuss the role of surgical therapy in advanced ovarian cancer on the sidelines of the American cancer conference ASCO 2026. The focus is on recent analyses of the TRUST study comparing primary […]

PROTEUS Study: Perioperative Therapy for High-Risk Prostate Cancer

This Medudy course is a video podcast for physicians on the topic “The PROTEUS Study – Perioperative Systemic Therapy for High-Risk Prostate Cancer.” Prof. Dr. Axel Merseburger (Clinical Director and Chairholder, University Medical Center Schleswig-Holstein, Lübeck Campus) speaks with study co-author Prof. Dr. Boris Hadaschik (Clinical Director, University Medical Center Essen, West German Cancer Center) about the PROTEUS study, which was published simultaneously in the New England Journal of Medicine. The global […]

ASCO 2026 – Update on Early-Stage Breast Cancer

This Medudy course is a video podcast for physicians on the topic of “Early-Stage Breast Cancer – Highlights from ASCO 2026.” Prof. Dr. Maggie Banys-Paluchowski (gynecologist, Lübeck) and Prof. Dr. Julia Radosa (Hamburg) summarize the most important studies from the Oral Abstract Session on early-stage breast cancer. In the surgical field, the AXANA study (axillary surgical techniques following neoadjuvant chemotherapy), […]

Advances in the Treatment of Urothelial Carcinoma: The Bispecific ADC Iza-bren for MIUC

This Medudy course is a video tutorial for physicians on the topic “Advances in the Treatment of Urothelial Carcinoma: The Bispecific ADC Iza-bren for MIUC.” Prof. Dr. med. Günter Niegisch, senior physician at the Department of Urology at the University Hospital Düsseldorf and principal investigator of the Izabright-Bladder01 study, discusses the antibody-drug conjugate Iza-bren in the context of advanced urothelial carcinoma […]

Efficacy of the new lutamides in metastatic hormone-sensitive prostate cancer (mHSPC)

This Medudy course is a video tutorial for physicians on the topic of “The Efficacy of New Lutamides in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).” Prof. Dr. Peter Hammerer, Chief Physician at the Department of Urology at Braunschweig Municipal Hospital, presents an overview of the efficacy and clinical classification of the new androgen receptor inhibitors (“lutamides”) in metastatic hormone-sensitive prostate cancer (mHSPC). Topics covered include […]

AUA Key Highlights 2026

This Medudy course is a conference summary for physicians on the topic of “AUA Key Highlights 2026.” Prof. Dr. Axel S. Merseburger, Director of the Department of Urology at the Lübeck Campus of the University Medical Center Schleswig-Holstein, will summarize key study highlights from the conference for you. The results of the U.S. Phase II study ARASEC, which evaluated the efficacy and safety of […]

Approval of a denosumab biosimilar

This Medudy course is a video tutorial for physicians on the topic of “Approval of a denosumab biosimilar.” Dr. Peer Aries, Head of the Immunology Department in Hamburg, and Prof. Dr. Axel Merseburger, Director of the Department of Urology at the University Medical Center Schleswig-Holstein, present practical knowledge in this video regarding the approval and use of a biosimilar successor to denosumab. In […]

Adenocarcinomas of the stomach and the gastroesophageal junction: HER2, PD-L1, MSI, and CLDN18.2 in treatment decisions

This Medudy course is a video tutorial for physicians on the topic “Adenocarcinomas of the stomach and the gastroesophageal junction: HER2, PD-L1, MSI, and CLDN18.2 in treatment decision-making.” Prof. Dr. Sylvie Lorenzen, Senior Physician at the Department of Internal Medicine III at the Klinikum rechts der Isar of the Technical University of Munich, with a clinical focus on […]